Evaluation of the Bioavailability of Pramlintide

Summary

This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin.

Timeline

Start

2002-06

Primary completion

2002-12

Completion

2002-12

Drugs

Indications